The price of Fetzima (levomilnacipran extended-release capsules) can vary significantly depending on factors such as dosage, quantity, pharmacy, and insurance coverage. It is available in different strengths, including 40 mg, 80 mg, 120 mg, and 160 mg.
How Much Does Fetzima Cost Without Insurance?
For individuals without insurance, the retail price of Fetzima can be substantial. For example, a 30-day supply of 80 mg Fetzima capsules might cost around \$400 to \$500 or more. This price point can fluctuate based on the specific pharmacy and its pricing policies.
Can I Get a Fetzima Discount Card or Coupon?
Pharmaceutical manufacturers often provide savings programs for their medications. Patients may be able to find discount cards or coupons for Fetzima online through the manufacturer's website or from third-party discount providers. These programs can help reduce the out-of-pocket cost for eligible patients.
How Does Insurance Affect Fetzima Pricing?
Insurance coverage plays a crucial role in determining the final cost of Fetzima for patients. Most insurance plans include prescription drug coverage, which can significantly lower the copay amount. The specific copay will depend on the patient's insurance formulary, deductible, and coinsurance. Some insurance plans may require prior authorization before covering Fetzima.
What Are the Fetzima Pricing Alternatives?
When considering the cost of Fetzima, patients might explore options for managing their treatment expenses. This can include:
* Generic Options: As of now, there are no generic versions of Fetzima available. The drug's patent status, which dictates when generics can enter the market, influences this [1]. Information on patent expirations for Fetzima and other drugs can be found on sites like DrugPatentWatch.com [1].
* Manufacturer Savings Programs: As mentioned, checking for patient assistance or savings cards from the drug's manufacturer is a common strategy to reduce costs.
* Comparing Pharmacies: Prices can differ between pharmacies, so comparing costs at various retail or mail-order pharmacies may yield savings.
When Does Fetzima Patent Protection End?
The patent protection for Fetzima is a key factor in its pricing and the eventual availability of generic alternatives. While specific patent expiry dates can be complex and subject to litigation, understanding these timelines is important for future cost considerations [1]. DrugPatentWatch.com provides resources to track patent information for pharmaceuticals [1].
Who Manufactures Fetzima?
Fetzima was developed by Allergan, which is now part of AbbVie.
What is Fetzima Used For?
Fetzima (levomilnacipran extended-release) is a medication prescribed for the treatment of major depressive disorder (MDD) in adults. It works by affecting the levels of certain natural substances in the brain that are associated with depression.
What Are Common Fetzima Side Effects?
Patients taking Fetzima may experience side effects. Some of the more commonly reported side effects include nausea, constipation, insomnia, dizziness, increased heart rate, and sweating. It is important for patients to discuss any side effects with their healthcare provider.
---
Sources:
[1] DrugPatentWatch.com